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Abstract  
Background Evaluating interventions that may lead to a reduction in people diagnosed with 
tuberculosis (TB) in high-income low incidence countries is key to accelerate progress towards 
elimination. We assessed the effectiveness of pre-entry active TB and post-entry latent TB 
infection (LTBI) screening to reduce TB incidence and the effect of primary care access on TB 
incidence in new-entrant migrants to the UK. 
 
Methods We performed a population-based cohort study of migrants from 66 countries, who 
were negative for active TB at pre-entry screening between January 1, 2011 and December 31, 
2014 and were eligible for LTBI screening. We used record linkage to track their first contact 
with primary care, uptake of LTBI screening and development of active TB in England, Wales 
or Northern Ireland. To assess the effectiveness of the pre-entry screening programme we 
identified a control group of migrants not screened for active TB using the specific code for 
new-entrants registering in primary care within the NHS patient registration data system. Our 
primary outcome was development of active TB notified to the National Enhanced Surveillance 
System (ETS).  
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Findings Our cohort comprised 224234 migrants screened for active TB before entry to the 
UK, and a control group of 118738 migrants not screened for active TB. 1771 incident active 
TB cases were identified in the entire cohort of migrants who registered in primary care 
(n=222728), giving an incidence rate of 174 (95% CI 166-182) per 100000 person-years. In 
migrants not screened for LTBI (n=220277) those not screened for active TB (n=117691) were 
more likely to develop TB than those screened for active TB (n=102586) (IRR 1·49, 1·33-1·67; 
p <0·0001). 2451(1·1%) of the 222728 migrants registered in primary care were screened for 
LTBI, of whom 421 (17·18%) tested positive and 1961 (80·01%) tested negative; none 
developed active TB within the observed time period. Accounting for 17938 (8%) migrants 
who migrated to Scotland and Northern Ireland, 103990 (50·4%) of the 224234 migrants 
screened for active TB registered in primary care. Migrants settling in the least deprived areas 
had a decreased risk of developing TB (IRR 0·74, 0·62-0·89; p=0·002), and time from UK 
arrival to GP registration ≥ one year was strongly associated with increased risk of developing 
TB (IRR 2·96, 95% CI 2·59-3·38; p <0·0001).  
Interpretation Pre-entry TB screening, early primary care registration and LTBI screening are 
strongly and independently associated with lower TB incidence in new-entrant migrants.  
 
Funding National Institute for Health Research (NIHR) Health Protection Research Unit in 
Respiratory Infections, NIHR Imperial Biomedical Research Centre (BRC). 
Research in context  
 
Evidence before this study  
 
We searched PudMed and Web of Science for articles in English, Spanish or French on the 
effectiveness of screening for active TB and latent TB infection (LTBI) in migrants, and 
migrants’ healthcare access and migrant’s health in high-income countries published until 
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September 30 2018. We used the terms “TB screening” or “pre-entry TB screening”, “LTBI 
screening”, “migrant health” and “healthcare access”. We identified two recent systematic 
reviews on active TB and LTBI screening, and one article synthesising a series of literature 
reviews on migration and health. The available literature suggests that screening for active TB 
is efficient when targeted to migrants from higher TB incidence countries. The effectiveness 
of LTBI is limited by the large pool of migrants with LTBI, and targeted LTBI programmes 
must ensure high screening uptake and treatment completion to have the greatest individual 
and public health benefit. None of these studies assessed the effectiveness of active TB and 
LTBI screening on health outcomes in migrants. There is few evidence on migrants’ health 
status and outcomes, although some surveys done in European countries contain some 
information about the health of migrants, it is out of date. 
 
Added value of this study  
 
We followed a large cohort of migrants from 66 high TB incidence countries and, by 
documenting the length of time from UK arrival to their first contact with primary care, we 
were able to assess healthcare access. We identified groups of migrants within our cohort that 
were exposed or not exposed to two major interventions for TB control in the UK; pre-entry 
TB screening for active TB and post-entry screening for LTBI. We estimated the incidence of 
TB in each group, and could therefore, for the first time, not only assess the effectiveness of 
these two interventions on an important health outcome in migrants, but also measure the effect 
that migrants’ healthcare access may have on TB incidence in the UK. 
Implications of all the available evidence 
 
Independently to pre-entry active TB and post-entry LTBI screening, early primary care 
registration is associated with lower TB incidence in new-entrant migrants. Thus, removing 
barriers and facilitating early access to health services for new migrants is likely to reduce TB 
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in this population. The pre-entry and LTBI screening programmes are likely to be responsible 
for the reduction in TB incidence in the UK. However, the LTBI programme will only succeed 
by securing early access to health services, because its effectiveness may be compromised by 
low attendance to primary care. The pre-entry screening programme provides an opportunity 
to actively deliver health promotion to inform its participants about the LTBI screening and 
primary care registration upon UK arrival. Likewise, the compulsory payment of an 
immigration health surcharge must be coupled with information on entitlements and the 
importance of primary care registration as entry point to the health system in the UK. 
 
Introduction  
 
Tuberculosis (TB) is a continuing public health problem, but in several high-income countries, 
TB rates are at pre-elimination levels (<10 cases per million), suggesting that elimination may 
be possible through combining a number of interventions.1 In the UK, similar to other low-
incidence countries, TB epidemiology is characterised by the majority of cases occurring in 
people from high-incidence countries often as a result of progression of latent TB infection 
(LTBI).1, 2  
 
In 2017 the UK had the lowest number of cases 5567 and the lowest TB incidence rate since 
1990 (8·4 per 100000 population).3 The improvement of TB control in the UK, over the last 
years included the implementation of a number of interventions, such as the roll out of a pre-
entry TB screening programme for visa applicants from high TB incidence countries and, 
within the Collaborative Tuberculosis Strategy for England 2015-2020, a new programme for 
voluntary LTBI screening and treatment for all new-entrant migrants from high-incidence 
countries.4-7  
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Migrants from countries with high TB burden have a higher risk of developing TB in the initial 
years after arrival to the UK.2, 4 Although the strongest risk factor for progression from LTBI 
to TB is time since infection,8 in migrants additional factors may be important such as the stress 
produced by the migration and adaptation process, the presence of comorbidities and their 
living and work environment.9 Moreover, migrants may face barriers to access health 
services,10, 11 and this is of particular importance because LTBI screening is provided through 
primary care services.12 The major challenge for the LTBI programme is to ensure that it 
reaches all individuals at risk of LTBI reactivation early after their arrival to the UK. The 
population level effectiveness of LTBI and pre-entry screening interventions, and the effect of 
improving healthcare access, on reducing the TB burden in new-entrant migrants to the UK, 
and their larger effects on the UK TB epidemiology are still uncertain. 
 
In this comprehensive, large cohort study we followed migrants who tested negative for active 
TB at pre-entry screening, and tracked their journey within the National Health Service (NHS) 
and TB control programme starting from first contact with primary care, uptake of LTBI 
screening and development of active TB. Our goal was to assess the effectiveness of pre-entry 
and LTBI screening to reduce TB incidence and the effect of primary care access on TB 
incidence in new-entrant migrants to the UK. 
 
Methods 
 
Study design and participants 
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We performed a population-based cohort study of all migrants from 66 countries who screened 
negative for active TB pre-entry between January 1, 2011 and December 31, 2014, and who 
fulfilled the eligibility criteria for the national LTBI screening programme of being aged 16 to 
35 years, born in a high-incidence country (≥150/100000 or sub-Saharan Africa) and arriving 
in England within the last five years (appendix).  
 
Control groups were migrants from the same countries who registered in primary care but did 
not have pre-entry screening, these groups included migrants screened and not screened for 
LTBI and were identified by the flag-4 code within the NHS Patient Registration Data System 
(PRDS). The flag-4 code indicates that someone who registered with a NHS general 
practitioner (GP) in England and Wales was previously living overseas.13, 14 It is generated if 
an individual who registers for the first time with a GP, was either born outside the UK, or if 
the individual’s previous address was outside the UK.13, 14 
 
Record linkage 
 
We used deterministic record linkage15 to identify migrants’ primary care registrations up to 
June 30 2017 by linking to the PRDS, which holds records of all patients registered with 
primary care in England and Wales, to create a cohort of migrants registered and not registered 
in primary care (figure 1).  
 
The control group of migrants not screened for active TB was identified by extracting from the 
PRDS 586579 flag-4 registrations of individuals aged 16 to 35 years, recorded between January 
1, 2011 and December 31, 2014 in the Clinical Commissioning Groups (CCGs) areas where 
the LTBI programme has been rolled out in London, North of England and Midlands (figure 
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1). At the time of linkage on 30 September 2017, the LTBI programme had been rolled out in 
56 CCGs.2 After exclusion of 436149 individuals born in the UK or who were from countries 
not eligible for LTBI screening, we probabilistically linked this cohort of 150430 records to 
the cohort of 224234 migrants screened for active TB. The exclusion of 31692 records, 
common to both cohorts from the former, revealed a population of 118738 migrants that 
registered with primary care but were not screened for active TB (Figure 1). These two cohorts 
were probabilistically linked to the database of the national LTBI programme to assess LTBI 
screening uptake, and to generate four comparison groups: 1404 screened for active TB and 
LTBI, 102586 screened for active but not LTBI, 1047 not screened for active TB but screened 
for LTBI, and 117691 not screened for active TB or LTBI (Figure 1). Under programmatic 
conditions a migrant is diagnosed as LTBI positive using a single interferon gamma release 
assay (IGRA) blood test according to the manufactures cut-off for positivity.12 
 
The pre-entry active TB screening programme was initially done in 15 pilot countries from 
2005 onwards and then rolled out to 101 high TB burden countries (>40/100000) between May 
2012 and March 2014.4 However, our cohort started in January 2011. Therefore, we used the 
country of origin and its starting date of pre-entry screening, to stratify the cohort into two 
groups; migrants from countries with and without an active pre-entry screening programme 
(appendix), because the migrants not screened for active TB could be from countries that did 
not have an active pre-entry screening programme at their time of UK arrival. 
 
A validated probabilistic linkage method16 was used to identify cases of all forms of active TB 
by linking the records of all cohorts to the Enhanced Tuberculosis Surveillance (ETS) system 
to identify subsequent development of any form of active TB in England, Wales or Northern 
Ireland between January 1, 2011 and August 31, 2017 without geographical or country of birth 
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restrictions. A detail description of data sources and all variables used in the analysis is 
provided in the appendix. Cases notified within 90 days of the issue of a TB clearance 
certificate were assumed to be prevalent (not incident) cases missed by pre-entry screening and 
were excluded from incidence rate analyses.4 Cohort time started upon entry to UK, determined 
as the date the certificate of clearance was issued plus 30 days of average visa processing time, 
and ended by death, becoming an active incident case or the end of cohort time 31 August 
2017. 
 
Because the PRDS only records GP registrations in England and Wales, there was no data to 
identify primary care registrations in Scotland and Northern Ireland. Therefore, to calculate the 
total percentage of primary care registrations, after linkage to the database of the national LTBI 
programme and to ETS, we randomly excluded 8% of records, as validated previously4, from 
the group of migrants not registered in primary care (figure 1); according to the data for long-
term international migration to the UK, these percentage of migrants would have entered to 
Scotland and Northern Ireland between January 1, 2011 and December 31, 2014.17  
 
All databases were stored, processed and analysed at Public Health England (PHE). Under the 
UK Health and Social Care Act 2012, PHE has authority to hold and analyse national 
surveillance data for public health and research purposes. By taking part in the pre-entry and 
LTBI screening programmes, migrants consented for their data to be used by PHE and the NHS 
for research, monitoring and evaluation. The migrants’ pathway and each intervention is shown 
in (figure 2). 
 
Outcomes 
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Our primary outcome measure was new cases of active TB notified to the ETS either 
bacteriologically or clinically diagnosed, in keeping with its case definition.18, 19 The secondary 
outcomes were primary care registration and LTBI screening uptake. 
 
Statistical analysis 
We used multiple imputation by chained equations (MICE) 20 to produce imputed values for 
the following variables when they were missing; visa category, deprivation index, time from 
UK arrival to primary care registration and follow-up time; 100 imputed data sets were created 
and analysed according to Rubin’s rules.21 This approach accounts for the uncertainty in 
imputed values and obtain unbiased estimates if the missing at random assumption holds: 
namely that an unbiased prediction for the missing variable can be obtained, conditional on its 
specified relationship with observed covariates.21 The MICE method uses sequential 
regressions that specify a separate imputation model appropriate for each variable with missing 
data and uses the other complete variables as predictors.20, 22 
 
To identify risk factors for the primary outcome active TB cases and the secondary outcome 
LTBI screening uptake, each imputed dataset was analysed separately using univariate and 
multivariate Poisson and logistic regression models respectively, and the results were 
combined into a single multiple-imputation result.21 We used univariate and multivariate 
logistic regression to assess the factors associated with the secondary outcome primary care 
registration. The results are presented as odds ratios (OR), incidence per 100000 person-years 
and incidence rate ratios (IRR), with 95% CIs and two-sided p values. Baseline characteristics 
of study participants are presented as total counts and percentages. We did a sensitivity analysis 
to account for the imputation method using complete case analysis, and for emigration out of 
the UK in the IRR estimates by using only the person-year contributions of migrants that 
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remained in the UK until the end of follow-up according to visa category. A detailed description 
of the multiple imputation method and the sensitivity analysis is provided in the appendix. Stata 
version 15 was used for all statistical analysis. 
 
Results 
 
There were 485793 screening episodes for the pre-entry programme between January 1 2011 
and December 31 2014 (Figure 1). After exclusion of duplicates and applicants not eligible for 
LTBI screening and treatment, 224234 records were deterministically and probabilistically 
linked to the PRDS and ETS respectively, the baseline characteristics of the study participants 
are depicted in (Table 1).  
 
A total of 1828 TB cases were identified during the cohort time, of which 31 were prevalent. 
There were 26 incident cases in migrants with no evidence of primary care registration, and 
1771 incident cases in those registered in primary care; of these 672 were screened and 1099 
not screened for active TB. This includes all forms of TB; pulmonary and extra pulmonary 
among migrants registered in primary care, giving an incidence rate of 174 (95% CI 166-182) 
per 100000 person-years in a total follow-up time of 1015121 person-years with median 
follow-up of 4·5 years per person (IQR 2·06). In the intervention groups the incidence rate was 
139 (95% CI 129-150) and 206 (95% CI 194-218) per 100 000 person-years in migrants 
screened and not screened for active TB respectively (Figure 1). In migrants not screened for 
LTBI, those not screened for active TB were more likely to develop TB than migrants screened 
for active TB (Table 2). A further analysis stratified according to the presence of an operational 
pre-entry programme in the country of origin showed that, after adjustments, migrants from 
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countries without an operational programme had a higher risk of developing incident TB (2·39, 
2·06-2·77; p <0·0001) (appendix). None of the migrants screened for LTBI developed active 
TB within the observed time period. The majority of TB cases occurred within the first three 
years of arrival. The multivariate analysis of risk factors associated with incident TB in the 
222728 migrants registered in primary care adjusting for age, sex, visa category, region of 
origin and estimated TB incidence in country of origin, showed that migrants settling in the 
least deprived areas had a decreased risk of developing TB, while time from UK arrival to GP 
registration of equal or more than one year was strongly associated with increased risk of all 
forms of TB (Table 2). None of the databases used recorded the length of stay of each study 
participant in the UK after arrival, and any change in the length of stay would affect the time 
at risk of being diagnosed with active TB. Therefore, we performed a sensitivity analysis which 
showed that our results were stable when emigration was taken into account (appendix).  
 
The results of the linkage to PRDS showed that, accounting for 17938 (8%) migrants who 
migrated to Scotland and Northern Ireland, only 103 990 migrants (50·4%) registered with a 
GP after arrival to the UK. A multivariate analysis of factors associated with primary care 
registration showed that being male, having a work or family reunion visa category, being from 
the South East Asia, Eastern Mediterranean and Western Pacific WHO regions, along with not 
having a chest radiography done were associated with a decreased probability to register with 
primary care (Table 3). In contrast, migrants in the settlements and dependents visa category 
and those with abnormal chest radiography were more likely to register (Table 3). 
 
A total of 2451 (1·1%) of the 222728 migrants in the cohort registered in primary care were 
screened for LTBI; of which 421 (17·2%) were positive and 1961 (80·01%) were negative, 
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with a median follow-up time from the date of screening of 0·63 years ± IQR 0·67 per person 
(appendix). In a subsequent multivariate analysis, the age group 16-25 years, having a 
settlements and dependents or family reunion visa category, and being from the South East 
Asia and Eastern Mediterranean regions were more likely to be screened for LTBI (Table 4). 
Conversely, being male, from the Western Pacific region, from a country with estimated TB 
incidence of more than 350 cases per 100000 population, from the least and middle deprived 
group and being from a country without an operational pre-entry screening programme were 
all factors associated with being less likely to be screened (Table 4). 
 
Discussion 
 
We provide direct evidence of a positive association between the pre-entry and LTBI screening 
programmes and lower TB incidence in new-entrant migrants. Our study also demonstrates 
low levels of primary care registration among migrants from high TB incidence countries and 
a significant association between delayed access to primary care and the risk of developing 
active TB. We show that improving migrants’ primary care access would likely improve TB 
control in the UK.  
 
Systematic screening for active TB in migrants has emerged as a potential strategy to improve 
early TB diagnosis and outcomes, but there is dearth of data to prove its effectiveness as a 
public health intervention.1, 9, 23, 24 Notably, we provide novel evidence from a study including 
a non-intervention comparison group, that the pre-entry screening programme is also effective 
at reducing the number of incident TB cases after arrival to the UK. We speculate that this 
intervention may also have a TB awareness raising effect among its participants; in our study, 
migrants from countries with no operational programme were less likely to be screened for 
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LTBI and had the highest risk to develop TB. It is likely that the majority of migrants in the 
non-intervention group were screened upon UK arrival as part of the previous system.4, 9 In this 
scenario, our results indicate that pre-entry screening reduces incident TB when compared to 
upon arrival chest X-rays, thus this is another advantage to its suggested higher yield.25 
 
The epidemiology of TB in England supports the notion that LTBI treatment could be of great 
benefit for recent immigrants from countries with high TB burden. 2, 26-28 In our cohort, none 
of the participants that were screened for LTBI developed active TB within the observed time 
period, potentially indicating the benefit of this intervention to reduce the number of incident 
TB cases. However, our results indicate that the effectiveness of this intervention might be 
affected by low attendance to primary care, as only half of the eligible new-entrant migrants 
registered in primary care. Since primary care is most often the first contact of immigrants with 
the NHS,14 the LTBI programme will only succeed by securing early access to health services 
within the first year of UK arrival. 
 
Primary care is the first contact point with health services, and GPs in the UK are gatekeepers 
for the NHS and provide integrated care addressing diverse healthcare needs in a family and 
community context.29 The beneficial effect of primary care on health outcomes, may be 
accounted for by a combination of mechanisms that include a greater focus on prevention, and 
the early management of health problems.29 In our study, half of the participants did not register 
in a primary care facility and there was an association between the type of visa and the 
probability of registration. We recently found that migrants may lack clarity about legality and 
rights to access health care, have competing priorities or fear the consequences of their 
immigration status.30 It is also likely that this is a young cohort that tends to be relatively 
healthy upon arrival. However, it has been shown that this healthy migrant effect wanes with 
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length of residence in the host country, possibly due to the acquisition of unhealthy lifestyle 
habits and the new living and working conditions.31 Consistent with this observation, our data 
show that deprivation index is an independent predictor of disease occurrence with migrants 
settling in the most deprived areas being more likely to develop TB, and the majority of cases 
occur within two to three years of arrival. Thus, early primary care access represents an 
important opportunity to offer preventive interventions for TB such as LTBI screening and 
treatment, and for other comorbidities that render this population at higher risk of TB. 
 
Access to healthcare services regardless of migration or financial status is a key intervention 
for TB elimination,1 and one of the founding principles of the NHS is to provide universal and 
equitable healthcare according to need.32 However, migrants are affected by barriers to access 
health services, and the introduction of new reforms, such as removing the right of migrants 
without an indefinite leave to remain to access free NHS care, and demanding NHS frontline 
staff to identify and charge patients in hospital care, are likely to increase their exclusion from 
primary and hospital care.10, 11, 32 Our results highlight the adverse consequences that such 
reforms may have on migrants’ and public health. We found a strong association between 
length of time to primary care registration and the risk of developing active TB, and other 
studies identified challenges for accessing healthcare as a main barrier for TB diagnosis and 
treatment uptake33 Although the health of migrants is of rising interest worldwide, there is a 
lack of evidence on migrants’ health status and outcomes, due to the challenge of gathering 
reliable information.34, 35 Our study followed a large cohort of migrants from 66 countries and 
included key sociodemographic variables such as country of origin, visa category, age, sex, 
and deprivation index in the settlement area; all factors that might influence their health 
status.34 
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Our study has some limitations. We followed a well-defined cohort of migrants but cannot 
ascertain that all study participants remained in the UK until the end of follow-up. However, 
we performed a sensitivity analysis to account for emigration according to visa category and 
our results were consistent. Our study did not include data on undocumented migrants, thus our 
results may underestimate the reported associations, due to potential under-ascertainment of 
cases in that population which likely face more barriers to access health services than regular 
migrants; there could also be under-ascertainment in the number of TB cases due to emigration. 
Likewise, our analysis did not account for the presence of important comorbidities such as HIV 
that may increase the risk to develop active TB. In addition, though our results may be affected 
by missing information, we accounted for the uncertainty and potential bias introduced by 
missing values in some variables as far as possible using a multiple imputation model. Our data 
on LTBI screening have some caveats, because we cannot ascertain treatment uptake and 
completion as this data was not available, and the average follow-up time after LTBI screening 
was less than one year. The size of the LTBI screened population in our cohort is small, but the 
percentage of positive for LTBI is the same to the prevalence in the national cohort.2 We cannot 
rule out the presence of confounders because this is not a randomised trial, however, we 
adjusted for the most important known factors such as age, sex, TB incidence in country of 
origin and deprivation index. 
 
Our study supports the hypothesis that the pre-entry and LTBI screening programmes are likely 
to be responsible, at least in part, for the reduction in TB incidence in the UK as recently 
suggested, 36 and strongly suggests that promoting early access to health services for new 
migrants would substantially reduce TB in this population. The pre-entry programme could be 
actively used for health promotion to inform its participants about the LTBI screening and 
primary care registration upon UK arrival (figure 2). Likewise, since from April 2015 all non-
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EEA nationals must pay an immigration health surcharge,32 this would be an opportunity to 
inform about their entitlements and the importance of primary care registration as entry point 
to the health system (figure 2). Our data on LTBI screening points to a beneficial effect of this 
intervention and a further evaluation is now required to confirm our findings. We could expect 
that the careful consideration of these factors will accelerate the progress towards TB 
elimination in the UK. 
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Table 1 Baseline sociodemographic characteristics of study participants 
 
Overall study cohort 
(n=342972) 
Screened for active TB  
(n=224234) 
Not screened for active TB  
(n=118738) 
Age (years)   
16-25 103418 (46%) 35598 (30%) 
26-35 120816 (54%) 83140 (70%) 
Sex   
Female 97640 (44%) 55411 (46·7%) 
Male 125699 (56%) 63327 (53·3%) 
Type of visa    
Students 122459 (54·6%) 63758 (53·7%) 
Settlements and 
dependents 
75577 (33·7%) 41502 (35%) 
Work 15966 (7·1%) 6641 (5·6%) 
Family reunion 3766 (1·6%) 3242 (2·7%) 
Other 6404 (2·8%) 3595 (3%) 
WHO region   
Africa 42727 (19%) 33367 (28·1%) 
Americas 2 (0·00%) 20 (0·02%) 
South-East Asia 66960 (29·8%) 67784 (57%) 
Europe 68 (0·03%) 698 (0·6%) 
Eastern Mediterranean 109497 (48·8) 14024 (11·8%) 
Western Pacific 4980 (2·2%) 2845 (2·4%) 
WHO estimated TB 
incidence (per 
100000) 
  
40-149 3317 (1·4%) 4102 (3·4%) 
150-349 214492 (95·6%) 107088 (90·2%) 
>350 6425 (3%) 7548 (6·4%) 
Year of screening   
2011 73274 (32·6%) ·· 
2012 43507 (19·4%) ·· 
2013 41803 (18·6%) ·· 
2014 65650 (29·3%) ·· 
Chest radiography   
Normal 210002 (93·7%) ·· 
Abnormal 10333 (4·6%) ·· 
Not done 3815 (1·7%) ·· 
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Table 2 Univariate and multivariate analysis of factors associated with incident tuberculosis in migrants 
registered in primary care in England 
Migrants registered 
in primary care 
(n=222728) 
Rate per 100000 
person-years 
(95%CI)* 
Univariate IRR 
(95%CI) 
P Multivariate IRR 
(95%CI) 
P 
Age (years)      
16-25 155 (143-169) 0·84 (0·75-0·92) 0·001 0·88 (0·79-0·97) 0·017 
26-35 184 (174-195) 1·0  1·0  
Sex      
Female 146 (136-157) 1·0  1·0  
Male 200 (188-212) 1·36 (1·23-1·49) <0·0001 1·13 (1·00-1·27) 0·034 
Type of visa       
Students 184 (173-196) 1·0  1·0  
Settlements and 
dependents 
157 (145-170) 0·81 (0·69-0·94) 0·007 0·89 (0·75-1·05) 0·196 
Work 176 (140-222) 0·79 (0·51-1·21) 0·291 0·91 (0·57-1·45) 0·696 
Family reunion 376 (298-475) 2·20 (1·61-3·01) <0·0001 3·27 (1·98-5·39) <0·0001 
Other 74 (47-117) 0·40 (0·18-0·87) 0·023 0·51 (0·23-1·14) 0·102 
WHO region      
Africa 137 (122-153) 1·0  1·0  
Americas 0 0  0  
South-East Asia 190 (177-203) 1·38 (1·21-1·58) <0·0001 1·27 (1·08-1·49) 0·002 
Europe 0 0  0  
Eastern 
Mediterranean 
181 (167-196) 1·32 (1·15-1·51) <0·0001 1·46 (1·24-1·73) <0·0001 
Western pacific 157 (109-228) 1·14 (0·77-1·68) 0·487 1·51 (0·99-2·30) 0·053 
WHO estimated 
TB incidence (per 
100000) 
     
40-149 252 (196-325) 1·0  1·0  
150-349 174 (166-183) 0·69 (0·53-0·89) 0·005 1·35 (0·86-2·10) 0·180 
>350 121 (92-160) 0·48 (0·33-0·70) <0·0001 1·32 (0·77-2·26) 0·307 
Deprivation index      
1-3 deciles 182 (171-193) 1·0  1·0  
4-6 deciles 182 (168-198) 0·97 (0·87-1·08) 0·637 0·96 (0·86-1·07) 0·408 
7-10 deciles 124 (107-144) 0·65 (0·54-0·77) <0·0001 0·74 (0·62-0·89) 0·002 
Time to GP 
registration 
     
<1 year 136 (128-144) 1·0  1·0  
≥1 year 436 (402-474) 3·07 (2·69-3·52) <0·0001 2·96 (2·59-3·38) <0·0001 
Intervention      
Pre-entry (+)  
LTBI (+) 
0 0  0  
Pre-entry (+)  
LTBI (-) 
141 (130-152) 1·0  1·0  
Pre-entry (-)  
LTBI (-) 
205 (193-218) 1·45 (1·32-1·60) <0·0001 1·49 (1·33-1·67) <0·0001 
Pre-entry (-)  
LTBI (+) 
0 0  0  
 
*Incidence rate per 100000 person-years and (95%CI) were derived from one imputation because the MICE 
method does not provide a combined result from all imputations for incidence rates. The interventions are pre-
entry active TB and post-entry LTBI screening, the exposure to one of these interventions or both is indicated by 
positive (+) and negative (-) symbols. 
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Table 3: Univariate and multivariate analysis of factors associated with primary care registration in 
England and Wales  
Migrants screened 
for active TB  
(n=224234) 
Primary care 
registration 
(n=103990) 
No primary care 
registration 
(n=120244) 
Univariate OR 
(95%CI) 
P Multivariate OR 
(95%CI) 
P 
Age (years)       
16-25 46931 (45%) 56487 (47%) 0·92 (0·91-0·94) <0·0001 0·92 (0·90-0·94) <0·0001 
26-35 57059 (55%) 63757 (53%) 1·0  1·0  
Sex       
Female 55940 (54%) 41700 (35%) 1·0  1·0  
Male 48019 (46%) 77680 (65%) 0·46 (0·45-0·46) <0·0001 0·54 (0·53-0·55) <0·0001 
Type of visa        
Students 49938 (48%) 72521 (60·3%) 1·0  1·0  
Settlements and 
dependents 
45660 (43·9%) 29917 (24·8%) 2·21 (2·17-2·26) <0·0001 1·85 (1·81-1·89) <0·0001 
Work 4103 (3·9%) 11863 (9·8%) 0·50 (0·48-0·52) <0·0001 0·55 (0·53-0·57) <0·0001 
Family reunion 1578 (1·5%) 2188 (1·8%) 1·04 (0·98-1·11) 0·168 0·62 (0·57-0·67) <0·0001 
Other 2707 (2·6%) 3697 (3%) 1·07 (1·02-1·13) 0·018 0·71 (0·67-0·75) <0·0001 
WHO region       
Africa 24934 (24%) 17793 (14·8%) 1·0  1·0  
Americas 0 2 (0·00%) 0  0  
South-East Asia 24596 (23·6%) 42364 (35·2%) 0·41 (0·40-0·42) <0·0001 0·40 (0·39-0·41) <0·0001 
Europe 29 (0·03%) 39 (0·03%) 0·54 (0·33-0·90) 0·019 0·66 (0·39-1·13) 0·133 
Eastern 
Mediterranean 
52279 (50·2%) 57218 (47·5%) 0·64 (0·63-0·66) <0·0001 0·57 (0·56-0·59) <0·0001 
Western pacific 2152 (2%) 2828 (2·3%) 0·54 (0·50-0·57) <0·0001 0·51 (0·47-0·54) <0·0001 
WHO estimated 
TB incidence (per 
100000) 
      
40-149 1809 (1·7%) 1508 (1·2%) 1·0  1·0  
150-349 98371 (94·6%) 116121 (96·6%) 0·70 (0·65-0·75) <0·0001 0·86 (0·78-0·92) <0·0001 
>350 3810 (3·6%) 2615 (2·2%) 1·22 (1·11-1·33) <0·0001 1·13 (1·02-1·21) 0·012 
Year of screening       
2011 32588 (31·4%) 32588 (31·3%) 1·0  1·0  
2012 20371 (19·5%) 20371 (19·5%) 1·10 (1·07-1·13) <0·0001 0·97 (0·95-1·00) 0·099 
2013 21212 (20·4%) 21212 (20·4%) 1·29 (1·25-1·32) <0·0001 1·03 (1·00-1·06) 0·026 
2014 29819 (28·6%) 29819 (28·6%) 1·04 (1·01-1·06) <0·0001 0·86 (0·84-0·89) <0·0001 
Chest radiography       
Normal 98267 (94·5%) 111735 (93%) 1·0  1·0  
Abnormal 5015 (4·8%) 5318 (4·4%) 1·07 (1·02-1·11) 0·001 1·14 (1·10-1·20) <0·0001 
Not done 690 (0·6%) 3125 (2·6%) 0·25 (0·23-0·27) <0·0001 0·27 (0·24-0·29) <0·0001 
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Table 4 Univariate and multivariate analysis of factors associated with LTBI screening in migrants 
registered in primary care in England  
Migrants registered 
in primary care 
(n=222728) # 
Univariate OR 
(95%CI) 
P Multivariate OR 
(95%CI) 
P 
Age (years)     
16-25 1·39 (1·28-1·51) <0·0001 1·41 (1·30-1·53) <0·0001 
26-35 1·0  1·0  
Sex     
Female 1·0  1·0  
Male 0·64 (0·59-0·70) <0·0001 0·77 (0·70-0·85) <0·0001 
Type of visa      
Students 1·0  1·0  
Settlements and 
dependents 
2·49 (2·25-2·76) <0·0001 2·01 (1·79-2·26) <0·0001 
Work 0·70 (0·49-1·00) 0·054 1·24 (0·85-1·79) 0·247 
Family reunion 1·44 (1·03-2·00) 0·029 1·69 (1·10-2·60) 0·016 
Other 1·11 (0·78-1·59) 0·529 1·54 (1·07-2·22) 0·019 
WHO region     
Africa 1·0  1·0  
Americas 0  0  
South-East Asia 1·53 (1·35-1·73) <0·0001 1·41 (1·23-1·61) <0·0001 
Europe 0    
Eastern 
Mediterranean 
2·94 (2·61-3·31) <0·0001 2·22 (1·95-2·54) <0·0001 
Western pacific 0·54 (0·33-0·88) 0·015 0·48 (0·29-0·80) 0·005 
WHO estimated 
TB incidence (per 
100000) 
    
40-149 1·0  1·0  
150-349 1·15 (0·89-1·49) 0·278 1·22 (0·87-1·72) 0·238 
>350 0·24 (0·15-0·38) <0·0001 0·46 (0·27-0·76) 0·003 
Deprivation index     
1-3 deciles 1·0  1·0  
4-6 deciles 0·64 (0·58-0·70) <0·0001 0·71 (0·65-0·78) <0·0001 
7-10 deciles 0·22 (0·18-0·27) <0·0001 0·27 (0·21-0·33) <0·0001 
Time to GP 
registration 
    
<1 year 1·0  1·0  
≥1 year 0·93 (0·78-1·11) 0·447 0·90 (0·76-1·07) 0·249 
Cohort     
 Screened for active 
TB 
1·0  1·0  
Not screened for 
active TB 
0·65 (0·60-0·70) <0·0001 0·95 (0·87-1·05) 0·375 
Not screened for 
active TB with pre-
entry screening 
programme 
0·76 (0·70-0·83) <0·0001 1·03 (0·94-1·14) 0·449 
Not screened for 
active TB without 
pre-entry screening 
programme 
0·38 (0·32-0·44) <0·0001 0·63 (0·53-0·74) <0·0001 
 
*Frequency distributions are not shown because the table contains variables with imputed values and the MICE 
method does not provide a combined result for descriptive statistics. # Includes 103990 migrants screened for 
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active TB and registered in primary care and the control group of 118738 migrants registered in primary care but 
not screened for active TB  
 
Figure legends 
Figure 1: Study design and participants. 
 
Figure 2: Migrants’ pathway, interventions and missed opportunities for prevention. In the pre-
arrival stage red arrows indicate mandatory steps, and blue arrows represent missed 
opportunities for health promotion and prevention. 
